Unfortunately, Lineage's IPO price marked the high-water mark for the shares. They've gone on to lose more than half their ...

[Stay on top of transportation news: Get TTNews in your inbox.] Temperature-controlled storage and logistics giant Lineage Inc. is seeking to raise as much as $3.85 billion in its initial public ...

CARLSBAD, Calif.--(BUSINESS WIRE)--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, ...

Lineage trades at a NAV discount with recovery potential, a 6.1% yield at 64% payout, expanding scale, and catalysts from rates. Read why LINE stock is a buy.

Truist lowered the firm’s price target on Lineage (LINE) to $40 from $53 and keeps a Buy rating on the shares. The firm, which is lowering its ...

CARLSBAD, Calif., August 12, 2025--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel allogeneic, or "off the shelf", cell ...

Report details progress the Company has made towards its decades-long effort to build a more resilient and sustainable cold chain NOVI, Mich.--(BUSINESS WIRE)--Lineage Logistics ("Lineage" or “the ...

Lineage (LINE), the world’s largest cold storage operator, is trading over 50% below recent highs but remains a dominant industry force. LINE is well-positioned for long-term growth and industry ...